Biomednewsbreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress In Pivotal Study Of Berubicin For Glioblastoma Treatment
CNS Pharmaceuticals (NASDAQ: CNSP) announced updated results from its ongoing pivotal trial evaluating Berubicin, a <a target=_blank href= ...